Jeffrey M. Lipton

9.7k total citations
142 papers, 4.8k citations indexed

About

Jeffrey M. Lipton is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Jeffrey M. Lipton has authored 142 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Molecular Biology, 37 papers in Hematology and 21 papers in Genetics. Recurrent topics in Jeffrey M. Lipton's work include RNA modifications and cancer (60 papers), Cancer-related gene regulation (52 papers) and Epigenetics and DNA Methylation (31 papers). Jeffrey M. Lipton is often cited by papers focused on RNA modifications and cancer (60 papers), Cancer-related gene regulation (52 papers) and Epigenetics and DNA Methylation (31 papers). Jeffrey M. Lipton collaborates with scholars based in United States, France and Italy. Jeffrey M. Lipton's co-authors include Adrianna Vlachos, Eva Atsidaftos, Steven R. Ellis, David G. Nathan, Philip J. Landrigan, Clyde B. Schechter, Marianne C. Fahs, Joel Schwartz, Jerome Ritz and Blanche P. Alter and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jeffrey M. Lipton

136 papers receiving 4.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey M. Lipton United States 36 2.1k 1.2k 802 733 710 142 4.8k
Mark A. Vickers United Kingdom 40 1.0k 0.5× 1.5k 1.2× 1.1k 1.4× 602 0.8× 553 0.8× 108 5.1k
Theodor M. Fliedner Germany 38 918 0.4× 1.3k 1.0× 736 0.9× 383 0.5× 460 0.6× 201 4.6k
Allen S. Yang United States 32 4.3k 2.1× 793 0.7× 292 0.4× 814 1.1× 214 0.3× 70 5.8k
A P Sappino Switzerland 23 1.4k 0.6× 927 0.8× 467 0.6× 335 0.5× 155 0.2× 32 4.2k
Jean‐Pierre Grünfeld France 49 2.2k 1.0× 883 0.7× 1.0k 1.3× 1.4k 1.9× 473 0.7× 147 7.4k
Nejat Akar Türkiye 32 1.1k 0.5× 1.3k 1.1× 394 0.5× 411 0.6× 128 0.2× 273 3.7k
Daniel J. Nolan United Kingdom 34 2.8k 1.3× 1.1k 0.9× 861 1.1× 862 1.2× 372 0.5× 111 7.5k
Mario Pirastu Italy 36 878 0.4× 1.3k 1.1× 218 0.3× 801 1.1× 228 0.3× 135 3.5k
Christian Berthou France 37 1.5k 0.7× 2.0k 1.7× 1.0k 1.3× 269 0.4× 193 0.3× 200 5.3k
Arnold Kahn United States 36 1.8k 0.8× 434 0.4× 263 0.3× 421 0.6× 474 0.7× 74 4.3k

Countries citing papers authored by Jeffrey M. Lipton

Since Specialization
Citations

This map shows the geographic impact of Jeffrey M. Lipton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Lipton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Lipton more than expected).

Fields of papers citing papers by Jeffrey M. Lipton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Lipton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Lipton. The network helps show where Jeffrey M. Lipton may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Lipton

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Lipton. A scholar is included among the top collaborators of Jeffrey M. Lipton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Lipton. Jeffrey M. Lipton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giri, Neelam, Matthew Gianferante, Marcin W. Włodarski, et al.. (2018). Phenotypes of Diamond Blackfan Anemia Patients with RPL35A Haploinsufficiency Due to 3q29 Deletion Compared with RPL35A Single Nucleotide Variants or Small Insertion/Deletions. Blood. 132(Supplement 1). 3854–3854. 2 indexed citations
2.
Lipton, Jeffrey M., et al.. (2018). Erythropoiesis: insights into pathophysiology and treatments in 2017. Molecular Medicine. 24(1). 11–11. 97 indexed citations
3.
Farrar, Jason E., Jessica Kang, Nancy E. Seidel, et al.. (2018). Altered Epigenetic Maturation in Early Erythroid Cells from Diamond Blackfan Anemia Patients Treated with Transfusions, Corticosteroids, or in Remission. Blood. 132(Supplement 1). 752–752. 1 indexed citations
4.
5.
Lanikova, Lucie, Suchitra S. Acharya, Sabina Świerczek, et al.. (2014). The homozygous VHLD126N missense mutation is associated with dramatically elevated erythropoietin levels, consequent polycythemia, and early onset severe pulmonary hypertension. Pediatric Blood & Cancer. 61(11). 2104–2106. 23 indexed citations
6.
Singh, Sharon, Adrianna Henson, Lionel Blanc, et al.. (2014). p53-Independent Cell Cycle and Erythroid Differentiation Defects in Murine Embryonic Stem Cells Haploinsufficient for Diamond Blackfan Anemia-Proteins: RPS19 versus RPL5. PLoS ONE. 9(2). e89098–e89098. 33 indexed citations
7.
Vlachos, Adrianna, Lionel Blanc, & Jeffrey M. Lipton. (2014). Diamond Blackfan anemia: a model for the translational approach to understanding human disease. Expert Review of Hematology. 7(3). 359–372. 43 indexed citations
8.
Markello, Thomas C., Hannah Carlson-Donohoe, Murat Sincan, et al.. (2011). Sensitive quantification of mosaicism using high density SNP arrays and the cumulative distribution function. Molecular Genetics and Metabolism. 105(4). 665–671. 17 indexed citations
9.
Doherty, Leana, Mee Rie Sheen, Adrianna Vlachos, et al.. (2010). Ribosomal Protein Genes RPS10 and RPS26 Are Commonly Mutated in Diamond-Blackfan Anemia. The American Journal of Human Genetics. 86(4). 655–656. 5 indexed citations
10.
Ellis, Steven R. & Jeffrey M. Lipton. (2008). Chapter 8 Diamond Blackfan Anemia: A Disorder of Red Blood Cell Development. Current topics in developmental biology. 82. 217–241. 48 indexed citations
11.
Vlachos, Adrianna, Sarah E. Ball, Niklas Dahl, et al.. (2008). Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. British Journal of Haematology. 142(6). 859–876. 297 indexed citations
12.
Weitzman, Sheila, et al.. (1999). Nucleoside analogues in the therapy of Langerhans cell histiocytosis: A survey of members of the Histiocyte Society and review of the literature. Medical and Pediatric Oncology. 33(5). 476–481. 38 indexed citations
13.
Vlachos, Adrianna, et al.. (1999). #779 Stem cell transplantation in Diamond Blackfan anemia. Journal of Pediatric Hematology/Oncology. 21(4). 340–340. 2 indexed citations
14.
15.
Alter, Blanche P., et al.. (1993). Lack of effect of corticosteroids in W/Wv and Sl/Sld mice: These strains are not a model for steroid‐responsive Diamond‐Blackfan anemia. European Journal Of Haematology. 50(5). 275–278. 6 indexed citations
16.
Lipton, Jeffrey M., et al.. (1992). Allogenic Bone Marrow Transplantation in Severe Gaucher Disease. Pediatric Research. 31(5). 503–507. 46 indexed citations
17.
Arkin, Steven, et al.. (1989). An intrinsic progenitor defect in Diamond‐Blackfan anaemia. British Journal of Haematology. 73(1). 112–120. 58 indexed citations
18.
Miller, Barbara A., Jeffrey M. Lipton, David C. Linch, Steven J. Burakoff, & David G. Nathan. (1985). Thy‐1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors. Journal of Cellular Physiology. 123(1). 25–32. 22 indexed citations
19.
Miller, Barbara A., M M Reid, Jeffrey M. Lipton, et al.. (1984). T‐cell acute lymphoblastic leukaemia with late developing Philadelphia chromosome. British Journal of Haematology. 56(1). 139–146. 24 indexed citations
20.
Lipton, Jeffrey M., et al.. (1980). Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation.. The Journal of Experimental Medicine. 152(2). 350–360. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Vickers Breakdown of academic impact, for papers by Theodor M. Fliedner Breakdown of academic impact, for papers by Allen S. Yang Breakdown of academic impact, for papers by A P Sappino Breakdown of academic impact, for papers by Jean‐Pierre Grünfeld Breakdown of academic impact, for papers by Nejat Akar Breakdown of academic impact, for papers by Daniel J. Nolan Breakdown of academic impact, for papers by Mario Pirastu Breakdown of academic impact, for papers by Christian Berthou Breakdown of academic impact, for papers by Arnold Kahn
Rankless by CCL
2026